<?xml version="1.0" ?><text author="Wojciech Marlicz, Anastasios Koulaouzidis" dateCollected="2019-11-03" id="autogum_academic_doc641" shortTile="small-bowelkey-player" sourceURL="https://www.mdpi.com/2077-0383/8/10/1748/htm" speakerCount="0" speakerList="none" title="Small Bowel — Key Player in Health and Disease" type="academic">
<p>
<s type="decl">
Over	IN	over
the	DT	the
last	JJ	last
two	CD	two
decades	NNS	decade
,	,	,
remarkable	JJ	remarkable
progress	NN	progress
has	VBZ	have
been	VBN	be
made	VBN	make
in	IN	in
understanding	VBG	understand
the	DT	the
etiology	NN	etiology
and	CC	and
pathophysiology	NN	pathophysiology
of	IN	of
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
New	JJ	New
discoveries	NNS	discovery
emphasize	VBP	emphasize
the	DT	the
importance	NN	importance
of	IN	of
the	DT	the
small	JJ	small
bowel	NN	bowel
(	-LRB-	(
SB	NNP	SB
)	-RRB-	)
‘	``	‘
ecosystem	NN	ecosystem
’	POS	's
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
acute	JJ	acute
and	CC	and
chronic	JJ	chronic
illness	NN	illness
alike	JJ	alike
.	.	.
</s>
<s type="decl">
Emerging	VBG	emerge
factors	NNS	factor
,	,	,
such	JJ	such
as	IN	as
microbiome	NN	microbiome
,	,	,
stem	NN	stem
and	CC	and
progenitor	NN	progenitor
cells	NNS	cell
,	,	,
innate	JJ	innate
intestinal	NN	intestinal
immunity	NN	immunity
,	,	,
and	CC	and
the	DT	the
enteric	JJ	enteric
nervous	JJ	nervous
system	NN	system
,	,	,
along	RB	along
with	IN	with
mucosal	NN	mucosal
and	CC	and
endothelial	NN	endothelial
barriers	NNS	barrier
,	,	,
play	VB	play
a	DT	a
key	JJ	key
role	NN	role
in	IN	in
the	DT	the
development	NN	development
of	IN	of
gastrointestinal	JJ	gastrointestinal
(	-LRB-	(
GI	NNP	GI
)	-RRB-	)
and	CC	and
extra-GI	JJ	extra-GI
diseases	NNS	disease
.	.	.
</s>
<s type="decl">
The	DT	the
results	NNS	result
of	IN	of
other	JJ	other
studies	NNS	study
point	NN	point
also	RB	also
towards	IN	towards
a	DT	a
link	NN	link
between	IN	between
the	DT	the
digestive	JJ	digestive
tract	NN	tract
and	CC	and
common	JJ	common
non-communicable	JJ	non-communicable
diseases	NNS	disease
,	,	,
such	JJ	such
as	IN	as
obesity	NN	obesity
and	CC	and
cancer	NN	cancer
.	.	.
</s>
<s type="decl">
These	DT	these
discoveries	NNS	discovery
unravel	VBP	unravel
novel	NN	novel
dimensions	NNS	dimension
of	IN	of
uncertainty	NN	uncertainty
in	IN	in
the	DT	the
area	NN	area
of	IN	of
clinical	JJ	clinical
decision-making	NN	decision-making
motivating	VBG	motivate
researchers	NNS	researcher
to	TO	to
search	VB	search
for	IN	for
novel	NN	novel
diagnostic	JJ	diagnostic
and	CC	and
therapeutic	JJ	therapeutic
solutions	NNS	solution
.	.	.
</s>
</p>
<p>
<s type="decl">
Recent	JJ	Recent
studies	NNS	study
unravel	VBP	unravel
the	DT	the
role	NN	role
of	IN	of
the	DT	the
poorly-understood	JJ	poorly-understood
complexity	NN	complexity
of	IN	of
the	DT	the
SB	NNP	SB
.	.	.
</s>
<s type="decl">
Insights	NNS	insight
into	IN	into
its	PRP$	its
critical	JJ	critical
physiologic	NN	physiologic
and	CC	and
pathophysiologic	JJ	pathophysiologic
role	NN	role
in	IN	in
metabolic	NN	metabolic
homeostasis	NN	homeostasis
and	CC	and
its	PRP$	its
potential	JJ	potential
role	NN	role
as	IN	as
a	DT	a
driver	NN	driver
of	IN	of
obesity	NN	obesity
,	,	,
insulin	NN	insulin
resistance	NN	resistance
,	,	,
and	CC	and
subsequent	JJ	subsequent
type	NN	type
2	CD	2
diabetes	NNS	diabete
mellitus	NN	mellitus
(	-LRB-	(
T2DM	NN	T2DM
)	-RRB-	)
have	VBP	have
been	VBN	be
revealed	VBN	reveal
.	.	.
</s>
<s type="decl">
For	IN	for
example	NN	example
,	,	,
bypassing	VBG	bypass
the	DT	the
proximal	JJ	proximal
small	JJ	small
intestine	NN	intestine
by	IN	by
means	NNS	means
of	IN	of
bariatric	NN	bariatric
surgery	NN	surgery
results	NNS	result
in	IN	in
a	DT	a
significant	JJ	significant
metabolic	NN	metabolic
benefit	NN	benefit
to	TO	to
an	DT	an
individual	JJ	individual
undergoing	VBG	undergo
such	PDT	such
a	DT	a
procedure	NN	procedure
.	.	.
</s>
<s type="frag">
Moreover	RB	moreover
,	,	,
endoscopic	JJ	endoscopic
procedures	NNS	procedure
aimed	VBN	aim
at	IN	at
placing	VBG	place
devices	NNS	device
separating	VBG	separate
luminal	JJ	luminal
contents	NNS	content
from	IN	from
the	DT	the
duodenal	NN	duodenal
mucosa	NN	mucosa
result	NN	result
in	IN	in
modest	JJS	modest
weight	NN	weight
loss	NN	loss
and	CC	and
improvement	NN	improvement
in	IN	in
glucose	NN	glucose
homeostasis	NN	homeostasis
.	.	.
</s>
</p>
<p>
<s type="decl">
Another	DT	another
endoscopic	JJ	endoscopic
treatment	NN	treatment
which	WDT	which
aims	VBZ	aim
at	IN	at
resurfacing	VBG	resurface
duodenal	NN	duodenal
mucosa	NN	mucosa
(	-LRB-	(
DMR	NNP	DMR
,	,	,
duodenal	NN	duodenal
mucosal	FW	mucosal
resurfacing	NN	resurface
)	-RRB-	)
,	,	,
leads	VBZ	lead
to	TO	to
improvement	NN	improvement
in	IN	in
glycemia	NN	glycemia
and	CC	and
insulin	NN	insulin
resistance	NN	resistance
in	IN	in
patients	NNS	patient
with	IN	with
T2DM	NNP	T2DM
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
not	RB	not
surprising	VBG	surprising
when	WRB	when
we	PRP	we
recall	VBP	recall
that	IN	that
SB	NNP	SB
endocrine	JJ	endocrine
cells	NNS	cell
secrete	VBP	secrete
glycemia-regulating	VBG	glycemia-regulating
incretin	NN	incretin
hormones	NNS	hormone
(	-LRB-	(
e.	FW	e.
g.	FW	g.
,	,	,
glucagon-like	NN	glucagon-like
peptide	NN	peptide
,	,	,
GLP-1	NNP	GLP-1
)	-RRB-	)
,	,	,
and	CC	and
this	DT	this
process	NN	process
is	VBZ	be
dependent	VBN	dependent
on	IN	on
food	NN	food
content	NN	content
in	IN	in
the	DT	the
intestinal	NN	intestinal
lumen	NN	lumen
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
bile	NN	bile
acids	NNS	acid
with	IN	with
various	JJ	various
targets	NNS	target
in	IN	in
the	DT	the
liver	NN	liver
and	CC	and
small	JJ	small
intestine	NN	intestine
(	-LRB-	(
e.	FW	e.
g.	FW	g.
,	,	,
farnesoid	NN	farnesoid
receptor	NN	receptor
,	,	,
FXR	NNP	FXR
)	-RRB-	)
together	RB	together
with	IN	with
a	DT	a
plethora	NN	plethora
of	IN	of
other	JJ	other
small	JJ	small
signaling	NN	signal
molecules	NNS	molecule
act	VBP	act
in	IN	in
concert	NN	concert
in	IN	in
regulating	VBG	regulate
metabolic	NN	metabolic
and	CC	and
digestive	NN	digestive
GI	NN	GI
function	NN	function
.	.	.
</s>
</p>
<p>
<s type="decl">
The	DT	the
human	JJ	human
digestive	JJ	digestive
tract	NN	tract
and	CC	and
enteric	NN	enteric
nervous	JJ	nervous
system	NN	system
(	-LRB-	(
ENS	NNP	ens
)	-RRB-	)
communicate	VBP	communicate
with	IN	with
the	DT	the
central	JJ	central
nervous	JJ	nervous
system	NN	system
(	-LRB-	(
CNS	NNP	CNS
)	-RRB-	)
through	IN	through
the	DT	the
gut-brain	JJ	gut-brain
axis	NN	axis
(	-LRB-	(
GBA	NNP	GBA
)	-RRB-	)
.	.	.
</s>
<s type="decl">
This	DT	this
bidirectional	JJ	bidirectional
communication	NN	communication
involves	VBZ	involve
diverse	JJ	diverse
neural	JJ	neural
networks	NNS	network
through	IN	through
the	DT	the
X	SYM	X
cranial	JJ	cranial
vagal	JJ	vagal
nerve	NN	nerve
—	:	—
dorsal	JJ	dorsal
roots	NNS	root
of	IN	of
the	DT	the
sympathetic/	JJ	sympathetic/
parasympathetic	JJ	parasympathetic
nervous	JJ	nervous
system	NN	system
.	.	.
</s>
<s type="decl">
Important	JJ	important
roles	NNS	role
in	IN	in
the	DT	the
regulation	NN	regulation
of	IN	of
the	DT	the
gut-brain	JJ	gut-brain
axis	NN	axis
are	VBP	be
played	VBN	play
by	IN	by
:	:	:
(	-LRB-	(
i	NNP	i
)	-RRB-	)
the	DT	the
hypothalamus-pituitary-adrenal	JJ	hypothalamus-pituitary-adrenal
axis	NN	axis
(	-LRB-	(
HPA	NNP	HPA
)	-RRB-	)
,	,	,
(	-LRB-	(
ii	NN	ii
)	-RRB-	)
the	DT	the
stress	NN	stress
hormones	NNS	hormone
(	-LRB-	(
cortisol	NN	cortisol
)	-RRB-	)
,	,	,
(	-LRB-	(
iii	NN	iii
)	-RRB-	)
the	DT	the
short-chain	JJ	short-chain
fatty	NN	fatty
acids	NNS	acid
(	-LRB-	(
SCFAs	NNP	SCFA
)	-RRB-	)
,	,	,
and	CC	and
(	-LRB-	(
iv	NN	iv
)	-RRB-	)
the	DT	the
gut	NN	get
microbiota	NN	microbiota
.	.	.
</s>
<s type="decl">
The	DT	the
intestinal	JJ	intestinal
barrier	NN	barrier
,	,	,
another	DT	another
important	JJ	important
part	NN	part
of	IN	of
GBA	NNP	GBA
,	,	,
is	VBZ	be
composed	VBN	compose
of	IN	of
:	:	:
(	-LRB-	(
i	CD	i
)	-RRB-	)
goblet	NN	goblet
cells	NNS	cell
derived	VBN	derive
mucus	NN	mucus
,	,	,
(	-LRB-	(
ii	NN	ii
)	-RRB-	)
microbiota	NN	microbiota
,	,	,
(	-LRB-	(
iii	NN	iii
)	-RRB-	)
epithelial	JJ	epithelial
cells	NNS	cell
,	,	,
(	-LRB-	(
iv	NN	iv
)	-RRB-	)
endothelial	NN	endothelial
cells	NNS	cell
,	,	,
(	-LRB-	(
v	NN	v
)	-RRB-	)
lymphatic	JJ	lymphatic
vessels	NNS	vessel
,	,	,
and	CC	and
v	NN	v
)	-RRB-	)
enterocytes	NNS	enterocyte
’	POS	's
tight	JJ	tight
cellular	JJ	cellular
junctions	NNS	junction
.	.	.
</s>
<s type="decl">
Of	IN	of
interest	NN	interest
,	,	,
the	DT	the
structure	NN	structure
and	CC	and
function	NN	function
of	IN	of
the	DT	the
intestinal	NN	intestinal
barrier	NN	barrier
resemble	VBP	resemble
that	IN	that
of	IN	of
the	DT	the
blood-brain	JJ	blood-brain
barrier	NN	barrier
(	-LRB-	(
BBB	NNP	BBB
)	-RRB-	)
.	.	.
</s>
<s type="decl">
The	DT	the
gut-brain	JJ	gut-brain
communication	NN	communication
is	VBZ	be
mediated	VBN	mediate
via	IN	via
blood	NN	blood
,	,	,
portal/hepatic	JJ	portal/hepatic
circulation	NN	circulation
,	,	,
and	CC	and
the	DT	the
bone	NN	bo
marrow	NN	marrow
.	.	.
</s>
</p>
<p>
<s type="decl">
Recently	RB	recently
,	,	,
it	PRP	it
has	VBZ	have
been	VBN	be
described	VBN	describe
that	IN	that
the	DT	the
alterations	NNS	alteration
of	IN	of
the	DT	the
intestinal	NN	intestinal
barrier	NN	barrier
play	VBP	play
a	DT	a
crucial	JJ	crucial
role	NN	role
in	IN	in
the	DT	the
pathology	NN	pathology
of	IN	of
several	JJ	several
human	JJ	human
inflammatory	JJ	inflammatory
and	CC	and
autoimmune	NN	autoimmune
diseases	NNS	disease
.	.	.
Mohanan	NNP	Mohanan
et	FW	et
al.	FW	al.
documented	VBD	document
the	DT	the
crucial	JJ	crucial
role	NN	role
of	IN	of
the	DT	the
C1orf106	CD	c1orf106
inflammatory	JJ	inflammatory
bowel	NN	bowel
disease	NN	disease
(	-LRB-	(
IBD	NNP	IBD
)	-RRB-	)
susceptibility	NN	susceptibility
gene	NN	gene
in	IN	in
stabilizing	VBG	stabilize
intestinal	NN	intestinal
barrier	NN	barrier
function	NN	function
and	CC	and
intestinal	NN	intestinal
inflammation	NN	inflammation
.	.	.
Manfredo	NNP	Manfredo
Vieira	NNP	Vieira
et	FW	et
al.	FW	al.
evidenced	VBD	evidence
the	DT	the
role	NN	role
of	IN	of
pathobionts	NNS	pathobiont
in	IN	in
the	DT	the
process	NN	process
of	IN	of
intestinal	JJ	intestinal
barrier	NN	barrier
alterations	NNS	alteration
,	,	,
which	WDT	which
were	VBD	be
followed	VBN	follow
by	IN	by
their	PRP$	their
translocation	NN	translocation
to	TO	to
lymph	NN	lymph
nodes	NNS	node
and	CC	and
the	DT	the
hepatic	JJ	hepatic
portal	NN	portal
system	NN	system
,	,	,
triggering	VBG	triggering
systemic	JJ	systemic
lupus	NN	lupus
erythematosus	NN	erythematosus
(	-LRB-	(
SLE	NNP	SLE
)	-RRB-	)
.	.	.
Thaiss	NNP	Thaiss
et	FW	et
al.	FW	al.
reported	VBD	report
that	IN	that
hyperglycemia	NN	hyperglycemia
leads	VBZ	lead
to	TO	to
disruption	NN	disruption
of	IN	of
the	DT	the
intestinal	JJ	intestinal
barrier	NN	barrier
followed	VBN	follow
by	IN	by
intestinal	JJ	intestinal
inflammation	NN	inflammation
and	CC	and
systemic	JJ	systemic
infection	NN	infection
.	.	.
Spadoni	FW	Spadoni
et	FW	et
al.	FW	al.
recently	RB	recently
documented	VBN	document
that	IN	that
the	DT	the
presence	NN	presence
of	IN	of
the	DT	the
gut-vascular	JJ	gut-vascular
barrier	NN	barrier
(	-LRB-	(
GVB	NNP	GVB
)	-RRB-	)
in	IN	in
the	DT	the
small	JJ	small
intestine	NN	intestine
controls	VBZ	control
the	DT	the
dissemination	NN	dissemination
of	IN	of
bacteria	NNS	bacteria
into	IN	into
the	DT	the
bloodstream	NN	bloodstream
.	.	.
</s>
<s type="decl">
The	DT	the
authors	NNS	author
reported	VBD	report
a	DT	a
decrease	NN	decrease
of	IN	of
the	DT	the
wnt/beta	JJ	wnt/beta
catenin-inducible	JJ	catenin-inducible
gene	NN	gene
Axin2	NNP	axin2
(	-LRB-	(
a	DT	a
marker	NN	marker
of	IN	of
stem	NN	stem
cell	NN	cell
renewal	NN	renewal
)	-RRB-	)
in	IN	in
gut	NN	get
endothelium	NN	endothelium
under	IN	under
the	DT	the
presence	NN	presence
of	IN	of
<hi rend="italic">
Salmonella	NNP	Salmonella
typhimirum	NN	typhimirum
</hi>
in	IN	in
the	DT	the
SB	NNP	SB
.	.	.
</s>
<s type="decl">
The	DT	the
GVB	NNP	GVB
was	VBD	be
modified	VBN	modify
in	IN	in
patients	NNS	patient
with	IN	with
coeliac	NN	coeliac
disease	NN	disease
(	-LRB-	(
CD	NN	CD
)	-RRB-	)
with	IN	with
altered	VBN	altered
serum	NN	serum
transaminases	NNS	transaminase
,	,	,
which	WDT	which
suggests	VBZ	suggest
that	IN	that
GVB	NNP	GVB
deterioration	NN	deterioration
may	MD	may
be	VB	be
responsible	JJ	responsible
for	IN	for
liver	NN	liver
damage	NN	damage
in	IN	in
CD	NN	CD
patients	NNS	patient
.	.	.
</s>
<s type="decl">
It	PRP	it
has	VBZ	have
been	VBN	be
shown	VBN	show
that	IN	that
disruption	NN	disruption
of	IN	of
epithelial	JJ	epithelial
and	CC	and
vascular	JJ	vascular
barriers	NNS	barrier
in	IN	in
the	DT	the
intestine	NN	intestine
were	VBD	be
early	JJ	early
events	NNS	event
in	IN	in
non-alcoholic	JJ	non-alcoholic
steatohepatitis	NN	steatohepatitis
(	-LRB-	(
NASH	NNP	NASH
)	-RRB-	)
,	,	,
and	CC	and
GVB	NNP	GVB
leakage	NN	leakage
marker	NN	marker
could	MD	could
be	VB	be
identified	VBN	identify
in	IN	in
colonic	NN	colonic
biopsies	NNS	biopsy
in	IN	in
patients	NNS	patient
with	IN	with
NASH	NNP	NASH
.	.	.
</s>
<s type="decl">
Of	IN	of
importance	NN	importance
,	,	,
SB	NN	SB
epithelial	JJ	epithelial
and	CC	and
vascular	JJ	vascular
barriers	NNS	barrier
are	VBP	be
FXR-controlled	NNP	FXR-controlled
,	,	,
which	WDT	which
opens	VBZ	open
avenues	NNS	avenue
to	TO	to
clinical	JJ	clinical
trials	NNS	trial
aimed	VBN	aim
at	IN	at
investigation	NN	investigation
of	IN	of
novel	NN	novel
FXR-agonists	NNS	FXR-agonists
as	IN	as
future	JJ	future
therapeutics	NNS	therapeutics
.	.	.
</s>
<s type="sub">
Of	IN	of
interest	NN	interest
,	,	,
intestinal	JJ	intestinal
barriers	NNS	barrier
could	MD	could
be	VB	be
monitored	VBN	monitor
in	IN	in
vivo	FW	vivo
with	IN	with
the	DT	the
aid	NN	avd
of	IN	of
confocal	NN	confocal
laser	NN	laser
endomicroscopy	NN	endomicroscopy
(	-LRB-	(
CLE	NNP	CLE
)	-RRB-	)
.	.	.
</s>
</p>
<p>
<s type="decl">
Therefore	RB	therefore
,	,	,
the	DT	the
SB	NNP	SB
is	VBZ	be
considered	VBN	consider
a	DT	a
key	JJ	key
player	NN	player
in	IN	in
metabolic	NN	metabolic
disease	NN	disease
development	NN	development
,	,	,
including	VBG	include
diabetes	NNS	diabete
mellitus	NN	mellitus
and	CC	and
NASH	NNP	NASH
,	,	,
and	CC	and
other	JJ	other
diet-related	JJ	diet-related
disorders	NNS	disorder
such	JJ	such
as	IN	as
coeliac	NN	coeliac
and	CC	and
non-coeliac	JJ	non-coeliac
enteropathies	NNS	enteropathie
.	.	.
</s>
<s type="decl">
Another	DT	another
major	JJ	major
field	NN	field
is	VBZ	be
drug	JJ	drug
metabolism	NN	metabolism
and	CC	and
its	PRP$	its
interaction	NN	interaction
with	IN	with
small	JJ	small
bowel	NN	bowel
microbiome	NN	microbiome
.	.	.
</s>
<s type="frag">
Moreover	RB	moreover
,	,	,
the	DT	the
emergence	NN	emergence
of	IN	of
gut-brain	NN	gut-brain
,	,	,
gut-liver	NN	gut-liver
,	,	,
and	CC	and
gut-blood	JJ	gut-blood
barriers	NNS	barrier
point	NN	point
towards	IN	towards
the	DT	the
important	JJ	important
role	NN	role
of	IN	of
the	DT	the
SB	NNP	SB
in	IN	in
the	DT	the
pathogenesis	NN	pathogenesis
of	IN	of
previously	RB	previously
unthought	JJ	unthought
and	CC	and
GI-unrelated	JJ	GI-unrelated
conditions	NNS	condition
such	JJ	such
as	IN	as
neurodegenerative	NN	neurodegenerative
and	CC	and
cardiovascular	NN	cardiovascular
disease	NN	disease
.	.	.
</s>
<s type="decl">
The	DT	the
SB	NNP	SB
remains	VBZ	remain
an	DT	an
organ	NN	organ
that	WDT	that
is	VBZ	be
difficult	JJ	difficult
to	TO	to
fully	RB	fully
access	VB	access
and	CC	and
assess	VB	assess
and	CC	and
accurate	JJ	accurate
diagnosis	NN	diagnosis
often	RB	often
poses	VBZ	pose
a	DT	a
clinical	JJ	clinical
challenge	NN	challenge
.	.	.
</s>
<s type="decl">
Undoubtedly	RB	undoubtedly
,	,	,
the	DT	the
therapeutic	JJ	therapeutic
potential	NN	potential
remains	VBZ	remain
untapped	JJ	untapped
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
it	PRP	it
is	VBZ	be
now	RB	now
time	NN	time
to	TO	to
direct	VB	direct
more	JJR	more
of	IN	of
our	PRP$	our
interest	NN	interest
towards	IN	towards
the	DT	the
SB	NNP	SB
and	CC	and
unravel	VB	unravel
the	DT	the
interplay	NN	interplay
between	IN	between
the	DT	the
SB	NNP	SB
and	CC	and
other	JJ	other
GI	NN	GI
and	CC	and
non-GI	JJ	non-GI
related	VBN	relate
diseases	NNS	disease
.	.	.
</s>
</p>
</text>